Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment

Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment

Western Cambodia is recognized as the epicenter of Plasmodium falciparum multidrug resistance. Recent reports of the efficacy of dihydroartemisinin (DHA)-piperaquine (PP), the latest of the artemisinin-based combination therapies (ACTs) recommended by the WHO, have prompted further investigations. T...

Full description

Bibliographic Details
Main Authors:	Leang, R, Taylor, WRJ, Bouth, DM, Song, L, Tarning, J, Char, MC, Kim, S, Witkowski, B, Duru, V, Domergue, A, Khim, N, Ringwald, P, Menard, D
Format:	Journal article
Language:	English
Published:	American Society for Microbiology 2015

Similar Items

Treatment failure of dihydroartemisinin/piperaquine for plasmodium falciparum malaria, Vietnam
by: Phuc, B, et al.
Published: (2017)

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
by: Bui Quang Phuc, et al.
Published: (2017-04-01)

Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients
by: Wanting Wu, et al.
Published: (2021-02-01)

Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area
by: Song Jianping, et al.
Published: (2011-08-01)

Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.
by: Amaratunga, C, et al.
Published: (2016)

Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study
by: Amaratunga, C, et al.
Published: (2016)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
by: Tarning, J, et al.
Published: (2008)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
by: Poespoprodjo, JR, et al.
Published: (2014)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.
by: Jeanne Rini Poespoprodjo, et al.
Published: (2014-01-01)

Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
by: Ashenafi Assefa, et al.
Published: (2022-12-01)

Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
by: Armedy Ronny Hasugian, et al.
Published: (2016-03-01)

Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
by: Armedy Ronny Hasugian, et al.
Published: (2016-03-01)

Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
by: Tran, T, et al.
Published: (2004)

Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
by: Ashenaf Assefa, et al.
Published: (2023-04-01)

Therapeutic and Transmission-Blocking  Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia
by: Jean Popovici, et al.
Published: (2018-08-01)

Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam
by: Thanh, N, et al.
Published: (2017)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
by: Rijken, M, et al.
Published: (2011)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
by: Tarning, J, et al.
Published: (2007)

Reproductive and endocrine effects of artemisinin, piperaquine, and artemisinin-piperaquine combination in rats
by: Xiaobo Li, et al.
Published: (2022-10-01)

Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
by: Rijken, M, et al.
Published: (2008)

Dihydroartemisinin - piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report
by: Rijken, M, et al.
Published: (2007)

Efficacy and safety of dihydroartemisinin-piperaquine.
by: Myint, H, et al.
Published: (2007)

Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum
by: Falq, G, et al.
Published: (2016)

Genetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study
by: Kwiatkowski, D, et al.
Published: (2016)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
by: Zongo, I, et al.
Published: (2014)

Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
by: van Der Pluijm, R, et al.
Published: (2019)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
by: Issaka Zongo, et al.
Published: (2014-01-01)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
by: Mytton, O, et al.
Published: (2007)

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
by: Hadjar Siswantoro, et al.
Published: (2015-01-01)

Efficacy of Artemisinin-Naphtoquine and Dihydroartemisinin-Piperaquine for uncomplicated malaria patient at primary health care
by: Hadjar Siswantoro, et al.
Published: (2015-01-01)

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
by: Permala, J, et al.
Published: (2017)

Evaluations of candidate markers of dihydroartemisinin-piperaquine resistance in Plasmodium falciparum isolates from the China–Myanmar, Thailand–Myanmar, and Thailand–Cambodia borders
by: Run Ye, et al.
Published: (2022-04-01)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
by: Byakika-Kibwika, P, et al.
Published: (2019)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
by: Pauline Byakika-Kibwika, et al.
Published: (2019-12-01)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
by: Chotsiri, P, et al.
Published: (2017)

Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine
by: Seila Suon, et al.
Published: (2010-02-01)

Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children.
by: Karema, C, et al.
Published: (2006)

Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
by: Ashley, E, et al.
Published: (2004)

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
by: Hasugian, A, et al.
Published: (2007)

Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia.
by: Witkowski, B, et al.
Published: (2013)